Sepsis-induced immune dysfunction: can immune therapies reduce mortality?

Area of Science:

• Immunology
• Critical Care Medicine
• Infectious Diseases

Background:

• Sepsis, a life-threatening infection response, historically linked to inflammatory/anti-inflammatory imbalances.
• Advances in critical care reduced early sepsis mortality, but late mortality persists.
• This late mortality surge highlights sustained immune alterations post-sepsis.

Purpose of the Study:

• To investigate the persistent immune cell dysfunction following sepsis.
• To identify mechanisms driving late mortality after sepsis recovery.
• To explore immune-modulatory therapies for sepsis-induced immunosuppression.

Main Methods:

• Review of recent studies on sepsis-induced immune alterations.
• Analysis of immune function changes in patients after acute sepsis events.
• Focus on identifying targets for immune-modulatory interventions.

Main Results:

• Sepsis causes sustained alterations in both innate and adaptive immunity.
• Immunosuppression is a significant and persistent immune change post-sepsis.
• Persistent immune cell dysfunction correlates with increased mortality after sepsis.

Conclusions:

• Late mortality in sepsis is linked to persistent immune dysfunction.
• Understanding and reversing sepsis-induced immunosuppression is crucial.
• Immune-modulatory therapies offer potential for improving long-term sepsis survival.